Change in Health-Related Quality of Life Among Individuals With Cancer Undergoing Smoking Cessation Treatment Involving Varenicline.
cancer
nursing
oncology
quality of life
smoking cessation
varenicline
Journal
Oncology nursing forum
ISSN: 1538-0688
Titre abrégé: Oncol Nurs Forum
Pays: United States
ID NLM: 7809033
Informations de publication
Date de publication:
04 01 2021
04 01 2021
Historique:
entrez:
18
12
2020
pubmed:
19
12
2020
medline:
18
9
2021
Statut:
ppublish
Résumé
To determine whether health-related quality of life (HRQOL) among individuals with cancer is undermined by smoking cessation treatment involving varenicline. Participants (N = 103) were daily smokers with cancer (up to five years postdiagnosis) who completed a placebo-controlled trial of standard versus extended duration varenicline. For this secondary study, participants were selected based on having completed the SF-12® at weeks 0, 1, 12, and 24. Using separate repeated measures multivariate analysis of variance, change in SF-12 scores was evaluated by time and by cancer treatment, varenicline duration, and quit status at week 24. There was no change in any of the three HRQOL scores by time or by cancer treatment status, varenicline duration, or quit status. Average emotional HRQOL score across time was significantly higher for quitters versus smokers. Varenicline, including long-term treatment, does not appear to adversely affect HRQOL, which is highly relevant to oncology nurses who are well positioned to assist with the pharmacologic treatment of tobacco dependence.
Identifiants
pubmed: 33337436
doi: 10.1188/21.ONF.112-120
pmc: PMC7983103
mid: NIHMS1680598
doi:
Substances chimiques
Benzazepines
0
Nicotinic Agonists
0
Varenicline
W6HS99O8ZO
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
112-120Subventions
Organisme : NIDA NIH HHS
ID : K24 DA045244
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA060553
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA165001
Pays : United States
Références
Community Oncol. 2012 Nov 1;9(11):344-352
pubmed: 23175636
J Natl Compr Canc Netw. 2015 May;13(5 Suppl):643-5
pubmed: 25995418
JAMA Oncol. 2016 Mar;2(3):367-8
pubmed: 26605495
Indian J Palliat Care. 2017 Oct-Dec;23(4):445-450
pubmed: 29123353
Oncologist. 2019 Feb;24(2):229-238
pubmed: 30446582
J Clin Nurs. 2009 Jul;18(14):2066-77
pubmed: 19638062
Psychooncology. 2019 Aug;28(8):1702-1711
pubmed: 31212391
Oncology. 2010;78(5-6):289-301
pubmed: 20699622
Eur J Cardiothorac Surg. 2011 Dec;40(6):1432-7; discussion 1437-8
pubmed: 21498082
Chest. 2004 Dec;126(6):1733-41
pubmed: 15596667
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S50-S58
pubmed: 31211105
Nicotine Tob Res. 2012 Jan;14(1):75-8
pubmed: 22025545
J Support Oncol. 2009 Nov-Dec;7(6):229-36
pubmed: 20380331
J Palliat Med. 2018 Jun;21(6):746-750
pubmed: 29733246
Eur J Cancer. 2012 Jul;48(11):1593-601
pubmed: 22244802
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
N Engl J Med. 2019 Feb 7;380(6):512-515
pubmed: 30601710
Cancer. 2014 Jul 1;120(13):1914-6
pubmed: 24687615
Cochrane Database Syst Rev. 2017 Dec 15;12:CD001188
pubmed: 29243221
Semin Oncol Nurs. 2016 Aug;32(3):187-96
pubmed: 27539275
Popul Health Metr. 2016 Jul 11;14:22
pubmed: 27408606
Semin Oncol Nurs. 2008 Feb;24(1):16-26
pubmed: 18222148
Psychooncology. 2009 Jan;18(1):62-70
pubmed: 18570223
BMC Cancer. 2019 May 7;19(1):425
pubmed: 31064331
Annu Rev Nurs Res. 2009;27:243-72
pubmed: 20192107
J Clin Epidemiol. 1998 Nov;51(11):1171-8
pubmed: 9817135
Prev Med. 2004 Sep;39(3):449-57
pubmed: 15313083
Can Oncol Nurs J. 2019 Oct 1;29(4):258-266
pubmed: 31966018
Res Social Adm Pharm. 2018 Nov;14(11):1080-1084
pubmed: 29366669
Psychooncology. 2017 Oct;26(10):1576-1585
pubmed: 27943512
J Public Health Med. 1997 Jun;19(2):179-86
pubmed: 9243433
J Thorac Oncol. 2015 Nov;10(11):1532-7
pubmed: 26317914
Jpn J Clin Oncol. 2013 Jan;43(1):45-54
pubmed: 23166386
Psychooncology. 2019 Mar;28(3):561-569
pubmed: 30680852